News & Updates
Filter by Specialty:
Show Multimedia Only

Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
Just Now
byStephen Padilla
The addition of atezolizumab to first-line chemotherapy plus bevacizumab delivers significant improvements in survival among patients with PD-L1+ or PD-L1‒ persistent, recurrent, or metastatic (R/M) cervical cancer, results of a post hoc analysis of the BEATcc study have shown.
Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
Just Now
Real-world data support tirzepatide + hormone therapy for weight loss in postmenopausal women
21 Aug 2025
byAudrey Abella
In postmenopausal women with overweight or obesity, the use of tirzepatide alongside menopause hormone therapy appears to yield better weight loss outcomes than treating with tirzepatide alone, findings from a real-world analysis have shown.
Real-world data support tirzepatide + hormone therapy for weight loss in postmenopausal women
21 Aug 2025
Can pregnant, lactating people use lenacapavir to prevent HIV infection?
19 Aug 2025
byStephen Padilla
The use of lenacapavir is highly efficacious in pregnant and lactating people (PLP), with zero participants acquiring HIV, as shown by the results of the PURPOSE 1 study.